These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 20724129

  • 21. [Vysorel/Isorel--cancer drug from Viscum album. Documentation No.20].
    Kast A, Hauser SP.
    Schweiz Rundsch Med Prax; 1990 Mar 13; 79(11):332-4. PubMed ID: 2315589
    [Abstract] [Full Text] [Related]

  • 22. Long-term quality of life in premenopausal women with node-negative localized breast cancer treated with or without adjuvant chemotherapy.
    Joly F, Espié M, Marty M, Héron JF, Henry-Amar M.
    Br J Cancer; 2000 Sep 13; 83(5):577-82. PubMed ID: 10944595
    [Abstract] [Full Text] [Related]

  • 23. Modulation of the cellular and humoral immune responses of tumor patients by mistletoe therapy.
    Stein G, Henn W, von Laue H, Berg P.
    Eur J Med Res; 1998 Apr 08; 3(4):194-202. PubMed ID: 9533928
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Patients are talking about ... Iscador (mistletoe).
    Decker G.
    Clin J Oncol Nurs; 2001 Apr 08; 5(4):183-4. PubMed ID: 12690624
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Influence of postoperative complementary treatment with lectin-standardized mistletoe extract on breast cancer patients. A controlled epidemiological multicentric retrolective cohort study.
    Schumacher K, Schneider B, Reich G, Stiefel T, Stoll G, Bock PR, Hanisch J, Beuth J.
    Anticancer Res; 2003 Apr 08; 23(6D):5081-7. PubMed ID: 14981970
    [Abstract] [Full Text] [Related]

  • 29. Mistletoe lectin is not the only cytotoxic component in fermented preparations of Viscum album from white fir (Abies pectinata).
    Eggenschwiler J, von Balthazar L, Stritt B, Pruntsch D, Ramos M, Urech K, Rist L, Simões-Wüst AP, Viviani A.
    BMC Complement Altern Med; 2007 May 10; 7():14. PubMed ID: 17493268
    [Abstract] [Full Text] [Related]

  • 30. Mistletoe in conventional oncological practice: exemplary cases.
    Legnani W.
    Integr Cancer Ther; 2008 Sep 10; 7(3):162-71. PubMed ID: 18956494
    [Abstract] [Full Text] [Related]

  • 31. Safety of high-dose intravenous mistletoe therapy in pediatric cancer patients: A case series.
    Zuzak TJ, Wasmuth A, Bernitzki S, Schwermer M, Längler A.
    Complement Ther Med; 2018 Oct 10; 40():198-202. PubMed ID: 30219449
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Neurophysiological effects of mistletoe (Viscum album L.) on isolated rat intestines.
    Radenkovic M, Ivetic V, Popovic M, Mimica-Dukic N, Veljkovic S.
    Phytother Res; 2006 May 10; 20(5):374-7. PubMed ID: 16619366
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Weight gain and quality of life in women treated with adjuvant chemotherapy for early-stage breast cancer.
    McInnes JA, Knobf MT.
    Oncol Nurs Forum; 2001 May 10; 28(4):675-84. PubMed ID: 11383182
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Prospective study of long-term impact of adjuvant high-dose and conventional-dose chemotherapy on health-related quality of life.
    Buijs C, Rodenhuis S, Seynaeve CM, van Hoesel QG, van der Wall E, Smit WJ, Nooij MA, Voest E, Hupperets P, TenVergert EM, van Tinteren H, Willemse PH, Mourits MJ, Aaronson NK, Post WJ, de Vries EG.
    J Clin Oncol; 2007 Dec 01; 25(34):5403-9. PubMed ID: 18048822
    [Abstract] [Full Text] [Related]

  • 40. Patient' and social aspects related to complementary mistletoe therapy in patients with breast cancer: A systematic review commissioned by the German agency for Health Technology Assessment.
    Steigenberger C, Schnell-Inderst P, Flatscher-Thöni M, Plank LM, Siebert U.
    Eur J Oncol Nurs; 2023 Aug 01; 65():102338. PubMed ID: 37321128
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.